No takes yet. Share an insight, caveat, or question.
Observational study investigates clonal hematopoiesis effects on chemotherapy outcomes in breast cancer, suggesting its role as a biomarker.
Yang et al. (2026) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: